TLV monitors and analyses pharmaceutical prices, in Sweden and abroad.
The international price comparison report is part of TLV’s assignment to monitor developments in the Swedish pharmaceutical market from an international perspective. It is the fourth report of its kind.
The analysis is based on national list prices at AIP level (pharmacy purchase price).
The analysis compares the price of medicine used in Swedish outpatient care to that of 19 other European countries: Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Switzerland, Slovakia, and Spain.
Pharmaceuticals have been divided into segments based on the prerequisite for competition in Sweden; pharmaceuticals not exposed to competition and those exposed to competition, which includes all pharmaceuticals included as substitutes for the ‘product-of-the-month’ in March 2017. Pharmaceutical data has been grouped by substance, dosage form and strength.